“With a market capitalisation of under $30m, LTR represents deep value in the sector. A conservative conceptual valuation of LTR by BSCP generates an NPV per share of 12c, around 5x the current share price. There is ample capacity for the progressive rerating of LTR shares.”
Now I’m all for optimism BUT............
- Forums
- ASX - By Stock
- LTR
- Bridge Street Capital Report - Liontown Valuation 12c
Bridge Street Capital Report - Liontown Valuation 12c, page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LTR (ASX) to my watchlist
(20min delay)
|
|||||
Last
84.5¢ |
Change
-0.010(1.17%) |
Mkt cap ! $1.612B |
Open | High | Low | Value | Volume |
85.0¢ | 86.5¢ | 83.5¢ | $5.151M | 6.083M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 23487 | 84.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
85.0¢ | 286512 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 1641167 | 0.019 |
3 | 712500 | 0.018 |
3 | 794117 | 0.017 |
1 | 200000 | 0.015 |
1 | 60000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 1985261 | 1 |
0.021 | 1256198 | 4 |
0.022 | 1128862 | 5 |
0.023 | 1750000 | 3 |
0.024 | 480229 | 3 |
Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
Featured News
LTR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online